Deep learning and virtual drug screening
In this editorial, brought to RxNet members by Future Medicinal Chemistry, the authors discuss how the use of machine learning to virtually screen compound libraries promises to generate drug leads more efficiently and accurately.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>